A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models

  • Authors:
  • Ivelina Gueorguieva;Kayode Ogungbenro;Gordon Graham;Sophie Glatt;Leon Aarons

  • Affiliations:
  • Lilly Research Centre, Global PK/PD, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, United Kingdom;Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom;Pfizer Ltd., Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom;Lilly Research Centre, Global PK/PD, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, United Kingdom;Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom

  • Venue:
  • Computer Methods and Programs in Biomedicine
  • Year:
  • 2007

Quantified Score

Hi-index 0.00

Visualization

Abstract

The design of pharmacokinetic and pharmacodynamic experiments concerns a number of issues, among which are the number of observations and the times when they are taken. Often a model is used to describe these data and the pharmacokinetic-pharmacodynamic behavior of a drug. Knowledge of the data analysis model at the design stage is beneficial for collecting patient data for parameter estimation. A number of criteria for model-oriented experiments, which maximize the information content of the data, are available. In this paper we present a program, Popdes, to investigate the D-optimal design of individual and population multivariate response models, such as pharmacokinetic-pharmacodynamic, physiologically based pharmacokinetic, and parent drug and metabolites models. A pre-clinical and clinical pharmacokinetic-pharmacodynamic model describing the concentration-time profile and effect of an oncology compound in development is used for illustration.